Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
CABAZITAXEL Teva Inf Konz 60 mg/6ml Durchstf 6 ml
Drug
Cabazitaxel-Teva, Konzentrat zur Herstellung einer Infusionslösung
Zytostatikum
07.16.1. – cytostatics
HAM – Human medicine
KOINF – Concentrate for solution for infusion
S – synthetic products for human use
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
10/11/2022
10/10/2027
Dosage strength
Cabazitaxel-Teva 60 mg/6 ml, Konzentrat zur Herstellung einer Infusionslösung
Zytostatikum
01
Z – approved
Package
7680685970015
In trade from / since 10/11/2022
A/R – Authorised / referenced
1 vial(s)
001
Z – approved
Declaration
Component
60 mg cabazitaxelum
cabazitaxeli isopropanoli solvatum
cabazitaxeli isopropanoli solvatum
acidum citricum
1092 mg ethanolum anhydricum
polysorbatum 80
macrogolum 400
1092 mg ethanolum anhydricum
polysorbatum 80
macrogolum 400
Spezialitätenliste***
SL
-
-
2690.90
None
Yes
10%
Yes
Authorisation holder
7601001331709
Teva Pharma AG
Kirschgartenstrasse 14
4051 Basel (BS)
Kirschgartenstrasse 14
4051 Basel (BS)
Date of revision of the text
4/29/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.